Knight Therapeutics Inc. Stock Börse Stuttgart
Stocks
04K
CA4990531069
Pharmaceuticals
OTC Markets Traded|
Delayed
Börse Stuttgart
07:17:32 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 6.050 EUR | 0.00% |
|
+4.31% | +63.51% |
| 08-06 | Knight Therapeutics Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Knight Therapeutics Q2 Loss Narrows | MT |
| Market Cap | 961M 693M 598M 561M 511M 66.22B 974M 6.58B 2.58B 33.18B 2.6B 2.54B 110B | P/E 2026 * |
70.9x | P/E 2027 * | 36.8x |
|---|---|---|---|---|---|
| Enterprise Value | 961M 693M 598M 561M 511M 66.22B 974M 6.58B 2.58B 33.18B 2.6B 2.54B 110B | EV / Sales 2026 * |
1.75x | EV / Sales 2027 * | 1.76x |
| Free-Float |
53.01% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Knight Therapeutics Inc.
| 1 week | +4.31% | ||
| 1 month | -0.82% | ||
| 3 months | +15.24% | ||
| 6 months | +53.55% | ||
| Current year | +63.51% |
| 1 week | 5.65 |  | 6.05 |
| 1 month | 5.6 | | 6.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 57 | 2021-08-31 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 2020-03-29 |
Melanie Groleau
CTO | Chief Tech/Sci/R&D Officer | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Goodman
CHM | Chairman | 58 | 2021-08-31 |
James Gale
CHM | Chairman | 77 | - |
Robert Lande
BRD | Director/Board Member | 63 | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +4.31% | +59.21% | - | 693M | |
| +0.10% | +3.86% | +61.47% | +24.83% | 335B | |
| -0.48% | -3.14% | +22.44% | -14.74% | 68.69B | |
| +4.40% | +0.37% | +53.11% | +142.47% | 11.69B | |
| +0.89% | -1.08% | -2.58% | -0.10% | 8.35B | |
| -0.34% | -1.58% | -13.22% | -1.69% | 4.84B | |
| +1.45% | +2.07% | -26.84% | +19.90% | 4.42B | |
| +1.40% | -0.33% | +2.23% | +50.50% | 4.35B | |
| -0.19% | +2.55% | +13.07% | +59.73% | 2.81B | |
| -0.60% | -4.19% | -5.51% | -5.65% | 2.18B | |
| Average | +0.60% | -0.07% | +16.34% | +30.58% | 49.2B | |
| Weighted average by Cap. | -0.78% | +2.17% | +51.08% | +21.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 548M 395M 341M 320M 291M 37.76B 555M 3.75B 1.47B 18.92B 1.48B 1.45B 62.92B | 546M 394M 340M 319M 291M 37.66B 554M 3.74B 1.47B 18.87B 1.48B 1.45B 62.76B |
| Net income | 13.07M 9.42M 8.14M 7.63M 6.95M 901M 13.25M 89.48M 35.06M 451M 35.38M 34.62M 1.5B | 26.36M 19.01M 16.41M 15.39M 14.02M 1.82B 26.73M 180M 70.72M 910M 71.36M 69.82M 3.03B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 26-08-18 | €6.050 | 0.00% |
| 26-08-17 | €6.050 | +4.31% |
| 26-08-14 | €5.800 | +0.87% |
| 26-08-13 | €5.750 | 0.00% |
| 26-08-12 | €5.750 | -2.54% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GUD Stock
- 04K Stock
Select your edition
All financial news and data tailored to specific country editions
